FDA Inspection
Suresh Anne, M.D.Suresh Anne, M.D. – FDA Inspection, May 19, 2023
Record Details
This FDA Inspection record concerns Suresh Anne, M.D., with an inspection on May 19, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0e93834a-f706-4113-b82c-e9796d856b90
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1205635
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Suresh Anne, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 13, 2026 | Not classified | Detroit District Office | Bioresearch Monitoring: Human Drugs |
Other documents for Suresh Anne, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.